Universal Medical (02666.HK) subsidiary plans to issue corporate bonds with a total principal amount not exceeding RMB 1 billion.

Zhito Finance APP News, Universal Medical (02666.HK) announced that its wholly-owned subsidiary, China Universal Leasing Co., Ltd. (the issuer), has received approval from the China Securities Regulatory Commission to publicly issue domestic corporate bonds in China to qualified investors, with a total principal amount of up to RMB 8 billion. As of the date of this announcement, the remaining quota of the corporate bonds is RMB 2.9 billion. The corporate bonds are issued in tranches. The total principal amount of the issuer's 2026 third tranche of corporate bonds shall not exceed RMB 1 billion (inclusive of RMB 1 billion), with a base term of five years, attached with the issuer's redemption option, coupon rate adjustment option, and investors' put option at the end of the 3rd year and the end of the 4th year.